Q1 Production Life Science Regulatory Intelligence & Strategy Conference

Gail H. Javitt was a panelist during "Regulatory Implications on FDA’s Final Lab Developed Test (LDT) Rule: Changes, Requirements, and Challenges" at the Q1 Production Life Science Regulatory Intelligence & Strategy Conference.